Literature DB >> 21649721

Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.

Xiao Xu1, Xuyong Wei, Qi Ling, Jun Cheng, Bin Zhou, Haiyang Xie, Lin Zhou, Shusen Zheng.   

Abstract

BACKGROUND AND AIM: Portal vein tumor thrombus (PVTT) is one of the factors that can affect prognosis and survival of hepatocellular carcinoma (HCC). In the present study, we aimed to find out some biomarkers associated with vascular invasion features of HCC with the method of comparative proteomic analysis.
METHODS: The proteins were extracted from a pair of HCC tissues with PVTT and without PVTT, and then separated by two-dimensional polyacrylamide gel electrophoresis. Differentially expressed protein spots were identified by matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Further analysis of two proteins were completed using real-time fluorescence quantitative polymerase chain reaction and western-blot in 40 HCC tissues with PVTT (n = 20) and without PVTT (n = 20).
RESULTS: Among 465 protein spots displayed on the gels, 33 unique proteins (> twofold change, P < 0.01) were identified, including 24 upregulated in HCC tissue without PVTT and nine upregulated in HCC tissue with PVTT. The real-time fluorescence quantitative PCR showed no statistically significant difference between HCC tissues with PVTT and without PVTT for mRNA expressions of protein disulfide-isomerase, A6 (PDI A6) (P = 0.137) and apolipoprotein A-I (Apo A-I) (P = 0.718). However, compared with HCC tissues without PVTT, protein expression of PDI A6 was higher in HCC tissues with PVTT (P < 0.001), while protein expression of Apo A-I was lower in HCC tissues with PVTT (P = 0.012).
CONCLUSIONS: PDI A6 and Apo A-I are closely related to vascular invasion feature of HCC.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21649721     DOI: 10.1111/j.1440-1746.2011.06796.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

1.  Novel sequences of subgroup J avian leukosis viruses associated with hemangioma in Chinese layer hens.

Authors:  Wei Pan; Yulong Gao; Fenfen Sun; Litin Qin; Zaisi Liu; Bingling Yun; Yongqiang Wang; Xiaole Qi; Honglei Gao; Xiaomei Wang
Journal:  Virol J       Date:  2011-12-21       Impact factor: 4.099

2.  Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.

Authors:  Brian I Carr; Vito Guerra; Rossella Donghia; Seai Yilmaz
Journal:  J Gastrointest Cancer       Date:  2021-10-06

3.  Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.

Authors:  Xiao Xu; Zhikun Liu; Lin Zhou; Haiyang Xie; Jun Cheng; Qi Ling; Jianguo Wang; Haijun Guo; Xuyong Wei; Shusen Zheng
Journal:  J Exp Clin Cancer Res       Date:  2015-01-22

4.  14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α.

Authors:  Yufu Tang; Shupeng Liu; Nan Li; Weixing Guo; Jie Shi; Hongming Yu; Long Zhang; Kang Wang; Shangrong Liu; Shuqun Cheng
Journal:  Oncotarget       Date:  2016-03-29

5.  Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer.

Authors:  Soma Samanta; Shuzo Tamura; Louis Dubeau; Paulette Mhawech-Fauceglia; Yohei Miyagi; Hisamori Kato; Rich Lieberman; Ronald J Buckanovich; Yvonne G Lin; Nouri Neamati
Journal:  Oncotarget       Date:  2017-10-06

Review 6.  Emerging roles of protein disulfide isomerase in cancer.

Authors:  Eunyoug Lee; Do Hee Lee
Journal:  BMB Rep       Date:  2017-08       Impact factor: 4.778

7.  4E-BP1Thr46 Phosphorylation Association with Poor Prognosis in Quantitative Phosphoproteomics of Portal Vein Tumor Thrombus Revealed that 4E-BP1Thr46 Phosphorylation is Associated with Poor Prognosis in HCC.

Authors:  Xincong Lin; Yao Huang; Ying Sun; Xionghong Tan; Jiahe Ouyang; Bixing Zhao; Yingchao Wang; Xiaohua Xing; Jingfeng Liu
Journal:  Cancer Manag Res       Date:  2020-01-07       Impact factor: 3.989

8.  Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma.

Authors:  Aimin Li; Qun Yan; Xinmei Zhao; Jietao Zhong; Haiyun Yang; Zhiqiang Feng; Yanlei Du; Yadong Wang; Zenan Wang; Hong Wang; Yongjian Zhou; Side Liu; Yuqiang Nie
Journal:  Oncotarget       Date:  2016-01-05

9.  Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection.

Authors:  Xiao-Lu Ma; Xing-Hui Gao; Zi-Jun Gong; Jiong Wu; Lu Tian; Chun-Yan Zhang; Yan Zhou; Yun-Fan Sun; Bo Hu; Shuang-Jian Qiu; Jian Zhou; Jia Fan; Wei Guo; Xin-Rong Yang
Journal:  Oncotarget       Date:  2016-10-25

10.  Expression analysis of apolipoproteins AI & AIV in hepatocellular carcinoma: A protein-based hepatocellular carcinoma-associated study.

Authors:  Dipu Bharali; Basu Dev Banerjee; Mausumi Bharadwaj; Syed Akhtar Husain; Premashis Kar
Journal:  Indian J Med Res       Date:  2018-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.